BALAMINES

Balaji Amines Limited

NSE
Last Traded Price
₹2085 22.7 (1.1%)
Open
₹2074
High
₹2090
Low
₹2022.1
Prev Close
₹2062.3
Industry
Specialty Chemicals
Market Cap
6752.37 Cr

Price Chart

Loading chart data...
Data delayed by up to 5 minutes. Not live.

Filing History

Recent corporate announcements and filings for BALAMINES

Routine Negative
2026-10-01 12:39
CRITICAL RED FLAG DETECTED
- Food & Drug Administration (FDA) issued a Directions and Warning Letter dated January 10, 2025, regarding a technical-grade Propylene Glycol consignment sold for industrial use, which was later improperly used for pharmaceutical purposes by a third party. - No penalty, prosecution, or adverse order was passed against the Company. - The company has reviewed and tightened its sales and documentation practices to prevent recurrence. - There is no material impact on the financials or operations of the company. - The disclosure was delayed due to an initial interpretation of reporting requirements, subsequently submitted following a SEBI letter.
Governance Negative
2026-10-01 12:39
CRITICAL RED FLAG DETECTED
- Balaji Amines Limited received a Warning cum Advisory Letter from SEBI on September 30, 2026. - The action pertains to the non-submission of required disclosures under Regulation 30 regarding specific orders and letters. - The company stated there is no material impact on its financials, operations, or other activities.
Routine Negative
2026-10-01 12:34
CRITICAL RED FLAG DETECTED
- Director General of Foreign Trade issued an order against Balaji Amines Limited on August 13, 2024. - License put in Denied Entity List due to violation of Export Obligation. - Company stated there is no material impact on financials or operations. - Disclosure delayed due to interpretation of reporting requirements, submitted following SEBI communication.
Governance Neutral
2026-09-28 18:45
- Completion of tenure of Mr. Rajendrakumar Mohanprasad Tapadiya as Independent Director of Balaji Speciality Chemicals Limited (material subsidiary). - Tenure ended on September 28, 2026, upon completion of his second term. - Cessation is due to the regular completion of term and not a resignation.
Routine Neutral
2026-09-28 15:24
- Trading window closed with effect from October 1, 2026. - Closure relates to the declaration of Un-audited Financial Results for Q2/H1 ended September 30, 2026. - Window will reopen 48 hours after results declaration; Board meeting date to be informed later.
Business Update Positive
2026-09-24 15:39
- Balaji Amines Limited commenced commercial production at its new Acetonitrile (ACN) Plant with advanced technology on 24th September 2026. - The plant is located at Unit-III, Chincholi MIDC, Solapur, Maharashtra under the expansion and modernisation programme. - The installed capacity of the ACN plant has increased to 1,440 TPM (Tonnes Per Month). - The product caters to both domestic and international markets.
Business Update Positive
2026-09-15 18:44
- Balaji Amines Limited announced the withdrawal of its credit rating for bank loan facilities (₹1,950 million) by India Ratings and Research (Ind-Ra). - The withdrawal is on account of "No Due Certificates from the Banks", indicating repayment or termination of the facilities.
Business Update Positive
2026-09-12 13:56
- Balaji Amines Limited's credit rating by India Ratings and Research was withdrawn on September 12, 2026. This is due to the company having no outstanding bank loan exposure and receiving 'No Dues Certificates' from all bankers.
Business Update Neutral
2026-08-17 17:07
- Investor Meet & Plant Visit Schedule - Date: 25th August, 2026 - Event: Plant Visit followed by a management meet - Location: Solapur, Maharashtra - Mode: Physical Meeting - Participants: Analysts / Institutional Investors
Business Update Neutral
2026-08-13 13:02
- Concall Schedule - Concall Date: 21st August 2026 - Concall Time: 4:00 P.M. IST
Financials Positive
2026-07-27 19:34
- Consolidated Revenue ₹461Cr vs ₹367Cr (▲25.6% YoY) - EBITDA ₹121Cr vs ₹64Cr (▲89.1% YoY) - PAT ₹78Cr vs ₹37Cr (▲110.8% YoY) - EBITDA Margin 26% vs 17% (▲900bps)
Financials Positive
2026-07-27 18:15
- Consolidated Revenue ₹455.93 Cr vs ₹358.34 Cr (▲27.24% YoY) - EBITDA ₹121.40 Cr vs ₹63.71 Cr (▲90.53% YoY) - PAT ₹74.94 Cr vs ₹38.00 Cr (▲97.16% YoY) - EBITDA Margin 26.63% vs 17.78% (▲885bps)
Governance Positive
2026-07-13 22:47
- The 38th Annual General Meeting (AGM) was held on July 10, 2026, through Video Conference/OAVM. - All resolutions, including the adoption of Audited Financial Statements for FY 2025-26, were passed with the requisite majority. - A dividend of Rs. 11 per Equity Share was declared for the Financial Year 2025-26. - Mr. Ande Srinivas Reddy was re-appointed as Whole-time Director.
Routine Neutral
2026-07-10 17:21
New Filing detected. See link for details.
Routine Neutral
2026-06-27 17:39
- Trading window for Balaji Amines Limited will close from July 1, 2026. - This closure is ahead of the declaration of un-audited financial results for the quarter ended June 30, 2026. - The window will reopen 48 hours after the results are declared.
Financials Positive
2026-06-16 17:53
- Board recommended a final dividend of ₹11 per equity share for FY 2025-26. - The dividend is subject to shareholder approval at the AGM on July 10, 2026. - The Record Date for determining dividend entitlement is July 3, 2026. - Payment will be made within 30 days from the AGM approval.
Business Update Positive
2026-06-16 16:07
- Balaji Amines Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. - The report outlines the company's commitment to sustainable progress, stakeholder inclusivity, and responsible corporate citizenship. - It details initiatives in resource optimisation, waste minimisation, cleaner technologies, energy efficiency, water conservation, emission reduction, and social responsibility programs.
Governance Positive
2026-06-16 15:35
- Notice for 38th Annual General Meeting (AGM) on July 10, 2026, at 12:00 Noon IST. - FY26 Annual Report filed: consolidated revenue ₹1,454 Cr, PAT ₹169 Cr. Q4 PAT ▲62% YoY. - ₹11/share dividend recommended. FY27 outlook: 10-15% volume growth, 22-23% EBITDA margins.

Unlock Full History

Log in to view all historical filings for BALAMINES and get instant Telegram alerts when new announcements drop.

Login with Telegram